2026年3月2日，中生北控生物科技股份有限公司（股票代码：08247）发布截至2026年2月28日的股份变动月报。公告显示，公司本月内并无新增发行、购回或注销股份，整体股本结构保持稳定。
公司主要股本由H股及内资股构成。其中，H股已发行股本数量为64,286,143股；内资股为80,421,033股。两类股份的注册股本分别为人民币64,286,143元及人民币80,421,033元。报告期内，各类股份数量均无变动，公司确认符合香港联交所对公众持股量的最低要求。
同时，公告并未披露与期权、购回及其他股权激励安排相关的更新信息。公司表示，当前已发行股份合计144,707,176股，所有股份于本月月底保持不变。公司声明遵守香港联交所《上市规则》及相关法律法规。公告由公司秘书董渙樟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.